Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model

This publication has 30 references indexed in Scilit:

• Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: A dose–response effect dependent on endothelial nitric oxide synthase
  International Journal of Cardiology, 2009
• Disodium Disuccinate Astaxanthin Prevents Carotid Artery Rethrombosis and ex vivo Platelet Activation
  Pharmacology, 2008
• Astaxanthin: A Novel Potential Treatment for Oxidative Stress and Inflammation in Cardiovascular Disease
  The American Journal of Cardiology, 2008
• Nebivolol Reduces Nitroxidative Stress and Restores Nitric Oxide Bioavailability in Endothelium of Black Americans
  Circulation, 2005
• Atherothrombosis and High-Risk Plaque
  JACC, 2005
• Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
  Journal Of Hypertension, 2005
• Haematococcus astaxanthin: applications for human health and nutrition
  Trends in Biotechnology, 2003
• Endothelial function
  The American Journal of Cardiology, 2002
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
  Journal of Clinical Investigation, 1998
• Nitric oxide released from activated platelets inhibits platelet recruitment.
  Journal of Clinical Investigation, 1997